← Back to Search

PneumoniaCheck for Coronavirus

N/A
Waitlist Available
Led By Larry Anderson, MD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Being treated for an acute respiratory illness either as inpatients or outpatients at Emory University Hospital
English is a primary spoken language
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to hour 24
Awards & highlights

Study Summary

This trial is testing a new way to collect material from people's lungs to learn more about how the SARS-CoV-2 virus causes lung disease and is spread.

Eligible Conditions
  • Coronavirus

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to hour 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to hour 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sensitivity of Detecting SARS-CoV-2 RNA
Specificity of Detecting SARS-CoV-2 RNA
Secondary outcome measures
Detection of IFN gamma
Detection of IL-1 beta
Detection of IL-10
+13 more
Other outcome measures
Amount of IFN Gamma Detected
Amount of IL-10 Detected
Amount of IL-12p70 Detected
+16 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: SARS-CoV-2 PositiveExperimental Treatment1 Intervention
Participants who test positive for SARS-CoV-2 with the Polymerase Chain Reaction (PCR) test.
Group II: Healthy ControlsExperimental Treatment1 Intervention
Participants without any acute respiratory illness.
Group III: Non-COVID-19 Acute Respiratory IllnessActive Control1 Intervention
Participants who have an acute respiratory illness other than SARS-CoV-2 infection.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PneumoniaCheck
2021
N/A
~70

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,504 Total Patients Enrolled
Georgia Tech FoundationUNKNOWN
Larry Anderson, MDPrincipal InvestigatorEmory University
1 Previous Clinical Trials
37 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19
Larry J. Anderson 2021. "Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04912895.
~17 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top